Clinical Trials Directory

Trials / Completed

CompletedNCT04078841

Treating Post-Lyme Disease Syndrome With Acetogenins

Using ReaLife+ to Treat Post-Lyme Disease Syndrome

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Optimal Health Research · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS).

Detailed description

To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS). After failure of antibiotic therapy to relive persistent symptoms of Lyme Disease, the use of Acetogenins to elevate Post-Lyme Disease Syndrome.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTReaLife+ (RLP)RLP is a dietary supplement containing Acetogenins, vitamin, mineral and amino acids.
OTHERInert Brown powderBrown powder Inert brown powder to look similar to RLP

Timeline

Start date
2019-07-01
Primary completion
2019-11-14
Completion
2020-01-30
First posted
2019-09-06
Last updated
2020-02-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04078841. Inclusion in this directory is not an endorsement.

Treating Post-Lyme Disease Syndrome With Acetogenins (NCT04078841) · Clinical Trials Directory